ESC 365 - Finerenone according to insulin resistance in heart failure: the FINEARTS-HF trial

ESC2025 Premium Access

Finerenone according to insulin resistance in heart failure: the FINEARTS-HF trial

Session: Assessing fitness in heart failure patients: from basic to high-tech methods

Topic: Comorbidities

Speaker: Doctor J. Ostrominski (Boston, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor John Ostrominski

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

2 presentations

0 follower

5 more presentations in this session

Association between gardening activity and frailty in patients with heart failure

Speaker: Doctor M. Saito (Ozu, JP)

Prognostic value of machine learning-based automated frailty rating in elderly patients with chronic heart failure

Speaker: Doctor T. Tamura (Sapporo, JP)

Revisiting the cholesterol paradox in heart failure:the impact of heart failure severity and skeletal muscle loss

Speaker: Doctor R. SATO (Goettingen, DE)

The prognostic importance of sleep quality in patients with heart failure and sleep apnea: Data from the Norwegian heart failure registry

Speaker: Mr H. Nahoui (Oslo, NO)

Longitudinal changes in cerebral blood flow in patients with chronic heart failure: A cohort study using pseudo-continuous arterial spin labeling MRI to assess the impact of heart failure progression

Speaker: Doctor H. Suzuki (Sendai, JP)

Access the full session

Assessing fitness in heart failure patients: from basic to high-tech methods

Speakers: Doctor J. Ostrominski, Doctor M. Saito, Doctor T. Tamura, Doctor R. SATO, Mr H. Nahoui...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources